CRDA

Croda International PLC

Chemicals First-pass screen £4.0bn

390/1000 Overall fit

AI beneficiary 35% 30

Operating leverage 25% 55

Valuation 25% 30

Downside protection 15% 50

First-pass take

Mature specialty chemicals company with no AI exposure and margin pressure in 2024 (17.2% vs 18.9%). Strong FCF (£181m) and 1.4x leverage provide downside protection, but inherently cyclical business dependent on pharma pipelines and crop prices lacks secular growth drivers.

Flags

cyclicalno-valuation-datam-a-integrationmargin-pressure